RxDoctor Payments Data

Otis Warr, MD

Cardiology · Mountain Home, ARNPI 1043214323

Payments from drug & device makers

$1,822in general payments, 2019–2025

Across 100 payments — averaging $18.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$481
  • Abbott$230
  • Pfizer$193
  • Philips North America LLC$176
  • Shockwave Medical, Inc$147
  • Boston Scientific$130
  • plus $466 from 14 others

What the payments were for

  • Food & beverage$1,80299%
  • Education$201%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few cardiology providers in Arkansasto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$261,545
Medicare patients
1,724
Services billed
5,145

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban406$392,110
XareltoRivaroxaban227$219,555
EntrestoSacubitril/Valsartan88$95,880
MultaqDronedarone Hcl48$64,961
Repatha SureclickEvolocumab81$45,201
Praluent PenAlirocumab30$14,376
Atorvastatin Calcium834$6,277
Metoprolol Succinate399$5,759
Carvedilol505$3,432
Isosorbide Mononitrate ErIsosorbide Mononitrate248$3,254
Metoprolol Tartrate430$2,939
ClopidogrelClopidogrel Bisulfate355$2,568
Diltiazem 12hr ErDiltiazem Hcl11$2,191
Lisinopril444$2,089
Losartan Potassium219$2,063

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$193$392,110406 claims
NovartisEntresto$481$95,88088 claims
Sanofi-aventis U.S. LLCMultaq$13$64,96148 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few cardiology providers in Arkansason file to place this against a meaningful peer group, so we don't.

Other cardiology in Mountain Home

Where these figures come from

Is this you, or does something look wrong? →